the firm's post-grant practitioners are some of the most experienced in the country.

Technologies

Artificial Intelligence (AI)
Artificial Intelligence (AI)
Digital Health
Digital Health
Energy & Renewables
Energy & Renewables

Fast Facts

About Our

Law Firm

About Our Law Firm

Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.

Get to know our

History

Get to know our History

1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.

Our Local and

Global Reach

Our Local and Global Reach

Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.

A few of our

ACCOLADES

A few of our ACCOLADES

Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.

OPPORTUNITIES FOR YOUR

Career

OPPORTUNITIES FOR YOUR Career

From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.

A few ways to

GET In Touch

A few ways to GET In Touch
US Office

Telephone: 703-413-3000
Learn More +


Tokyo Office

Telephone: +81-3-6212-0550
Learn More +

Downloadable

Patent Forms

Downloadable Patent Forms

The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.

Stay informed with

Our Blogs

Navigating the Conflict Between CAFC Case Law and USPTO Guidance on Patent Eligibility

Schedule :

Associated People


Oblon, IAM Media and Lexology Webianrs co-hosted a webinar on August 11, 2021 entitled "Navigating the Conflict Between CAFC Case Law and USPTO Guidance on Patent Eligibility." 

This webinar will discuss the conflict between the USPTO patent eligibility guidance and the Federal Circuit case law and offer some suggestions on how to comply with both. The Federal Circuit has criticized and refused to even consider the USPTO guidance when reviewing district court patent invalidations and ex parte appeals from the PTAB. The districts courts have similarly declined to consider the guidance beginning with the Cleveland Clinic II case. The problem is that claims patent eligible under the USPTO Guidance may be ineligible under the Federal Circuit case law. Part of the problem is that the Federal Circuit’s opinions often do not set out the reasons for the decision with clarity and the other is the desire of the USPTO to try and develop simple rules for determining eligibility. The problem with this effort is that the USPTO is without the authority to promulgate substantive rules. This webinar will discuss the problems and suggest some techniques for threading the eye of the needle of patent eligibility.